Fulgent Genetics (FLGT) Profit After Tax (2015 - 2026)

Fulgent Genetics has reported Profit After Tax for 12 years, with the latest figure at -$29.7 million in Q2 2026.

• Quarterly Profit After Tax fell 54.34% year-over-year to -$29.7 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$85.5 million (down 64.24% YoY) and the FY2025 annual result came in at -$61.6 million, down 40.65% from the prior year.
• Profit After Tax declined to -$29.7 million in Q2 2026 per FLGT's latest filing, from -$25.3 million in the prior quarter.
• Over five years, Profit After Tax peaked at $153.6 million in Q1 2022 and troughed at -$134.3 million in Q4 2023.
• A 5-year average of -$10.7 million and a median of -$13.7 million in 2023 frame the typical range for Profit After Tax.
• The sharpest annual moves came in 2023 and 2024: Profit After Tax plunged 883.36% in 2023, then soared 95.39% in 2024.
• Over 5 years, Profit After Tax stood at -$24.1 million in 2022, then plunged by 457.96% to -$134.3 million in 2023, then jumped by 95.39% to -$6.2 million in 2024, then plunged by 282.07% to -$23.6 million in 2025, then decreased by 25.66% to -$29.7 million in 2026.
• According to Business Quant data, Profit After Tax over the past three periods registered -$29.7 million, -$25.3 million, and -$23.6 million for Q2 2026, Q1 2026, and Q4 2025 respectively.